Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma

NCT04776525 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Ifosfamide
DRUG: Doxorubicin

Sponsor

Oslo University Hospital

Collaborators

[object Object]